Assessment and Plan Example for Community-Acquired Pneumonia
How do you assess community-acquired pneumonia?
Start with the patient's history. Look for symptoms like a cough, fever, chest pain, and difficulty breathing. Ask about recent illnesses or exposure to sick contacts. Consider risk factors such as smoking, chronic illnesses, or recent travel.
During the physical exam, listen for abnormal lung sounds like crackles or decreased breath sounds. Check for signs of respiratory distress, such as increased respiratory rate or use of accessory muscles.
If needed, order a chest X-ray to confirm the diagnosis. Blood tests like a CBC can help assess the severity and look for complications.
What should be included in the plan for CAP?
Your treatment plan should start with antibiotics. The choice depends on the patient's age, comorbidities, and local resistance patterns. For outpatient treatment, consider:
- Amoxicillin
- Doxycycline
- Macrolides like azithromycin (if local resistance is low)
For patients with comorbidities or recent antibiotic use, consider a beta-lactam plus a macrolide or a respiratory fluoroquinolone.
Supportive care is also important. Recommend rest, hydration, and over-the-counter medications for fever and pain. Encourage smoking cessation if applicable.
When should you follow up with the patient?
Schedule a follow-up within 48 to 72 hours to ensure the patient is improving. If symptoms worsen or new symptoms develop, reassess and consider hospitalization.
For high-risk patients or those with severe symptoms, closer monitoring and possibly inpatient care might be necessary. Always consider the patient's overall health and social support when planning follow-up care.
Sources
- Jones BE, Ramirez JA, Oren E. Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline.. American journal of respiratory and critical care medicine (2026). PMID: 40679934.
- Reyes LF, Conway Morris A, Serrano-Mayorga C. Community-acquired pneumonia.. Lancet (London, England) (2025). PMID: 41110447.
- Dinh A, Lebeaux D. Duration of antibiotic treatment for community-acquired pneumonia.. Infectious diseases now (2025). PMID: 40749837.
- REMAP-CAP Investigators, Angus DC. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.. Intensive care medicine (2025). PMID: 40261382.